Skip to main content

Market Overview

7 Stocks To Watch For December 14, 2020

7 Stocks To Watch For December 14, 2020

Some of the stocks that may grab investor focus today are:

  • AstraZeneca plc (NASDAQ: AZN) announced plans buy Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) for $39 billion. AstraZeneca shares fell 4.4% to $51.86 in pre-market trading, while Alexion Pharmaceuticals shares gained 32.3% to $160.00 in the pre-market trading session.
  • Pluralsight Inc (NASDAQ: PS) agreed to be acquired by private-equity firm Vista Equity Partners in an all-cash transaction for $20.26 per share. Pluralsight shares climbed 7.1% to $20.32 in the pre-market trading session.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Choosing the best broker is an important part of being a successful trader or investor

  • Huntington Bancshares Incorporated (NASDAQ: HBAN) and TCF Financial Corp (NASDAQ: TCF) agreed to merge in an all-stock deal with a total market value of around $22 billion. TCF Financial shares fell 2.5% to close at $34.78 on Friday, while Huntington Bancshares shares slipped 0.8% to close at $12.93 on Friday.
  • Pfizer Inc. (NYSE: PFE) and its German partner BioNTech SE – ADR (NASDAQ: BNTX) reported that their Covid-19 vaccine candidate received the emergency use authorization from the US FDA for use in individuals aged 16 years and older. Pfizer shares gained 1.5% to $41.73 in after-hours trading, while BioNTech shares rose 0.4% to $127.79 in the pre-market trading session.

Related Articles (ALXN + AZN)

View Comments and Join the Discussion!

Posted-In: Stocks To WatchM&A News Pre-Market Outlook Markets Trading Ideas Best of Benzinga

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at